U.S. General Merchandise and Department Stores Stock News

Cross-border Chinese wealth management and brokerage stocks are suddenly under a harsh spotlight after the sentencing of tycoon Guo Wengui in the US for a billion-dollar fraud scheme. For you as an investor, this kind of shock can reshape how regulators, clients, and counterparties view risk around Chinese capital flows and financial platforms. This article explains how that shift may affect a handful of Chinese Wealth Management and Brokerage Stocks With Regulatory Exposure, and walks...

China’s latest PMI data points to a cautiously stabilising economy, with global demand for high-tech exports, AI hardware, and renewable equipment helping to offset weak local spending and a sluggish property sector. For investors, that combination of export strength and selective industrial profit growth creates a focused opportunity set, as some companies are more directly exposed to these cross-border AI and high-tech trends than others. This article breaks down 3 stocks from our AI and...

Middleby’s food processing spin-off, Midera Food Processing, Inc., previously entered a five-year, US$1.0 billion credit agreement with Bank of America and other lenders, comprising a US$750 million U.S. revolving facility and a US$250 million multi-currency revolving facility, with the separation targeted for completion on July 6, 2026, subject to conditions. This substantial financing package signals that Midera will launch as a stand-alone business with significant liquidity and capital...

Afya (NasdaqGS:AFYA) is back in focus after recent share performance, with the stock flat over the past day but up over the past week and month, prompting closer attention to its valuation and fundamentals. See our latest analysis for Afya. Over the past month Afya has shown improving momentum, with a 1 month share price return of 6.14% contrasting with a year to date share price return that is slightly down and a 1 year total shareholder return that has also declined. If you are comparing...

Recently, analyst commentary highlighted that Ubiquiti Inc. is expected to benefit from trends such as IoT proliferation, fiber densification, and 5G adoption, with earnings estimates revised upward despite persistent price competition and elevated raw material costs. This combination of rising earnings expectations and exposure to long-term network infrastructure themes has reinforced optimism about Ubiquiti’s business outlook across both emerging and developed markets. Next, we’ll examine...

Array Technologies (ARRY) is drawing attention after launching its DuraTrack D2S dual row solar tracker for international markets, with the first commercial installation already underway in Spain in early 2026. See our latest analysis for Array Technologies. Even with the DuraTrack D2S launch and a new shelf registration filing, Array Technologies’ share price has come under pressure, with the 30 day share price return down 21.59% and the 1 year total shareholder return still positive at...

Arbor Realty Trust, Inc. was recently removed from the Russell 2000 Dynamic Index, a move that typically prompts portfolio adjustments by index-tracking funds. This index exit may influence how investors view Arbor Realty Trust’s liquidity and visibility relative to other small-cap real estate finance names. We’ll now examine how Arbor Realty Trust’s removal from the Russell 2000 Dynamic Index could reshape its existing investment narrative. We've uncovered the 9 dividend fortresses yielding...

In late June 2026, MFA Financial, Inc. was added to multiple Russell benchmarks, including the Russell 2000 Growth-Defensive, Russell 2500 Growth, Russell 3000 Growth, Russell 3000E Growth, and the Russell Small Cap Comp Growth indices. This broad inclusion across Russell growth and small-cap indices significantly broadens MFA Financial’s presence in benchmark-driven portfolios, potentially increasing attention from institutional and rules-based investors. Now we’ll examine how MFA...

The FDA’s new PreCheck pilot is putting fresh attention on U.S. biopharmaceutical manufacturing stocks, as faster facility reviews could reshape how quickly companies bring complex therapies to market. With select facilities from Eli Lilly, Regeneron and others lined up for accelerated oversight, investors are watching which businesses might gain from quicker approvals, added capacity and stronger onshore supply chains, and which could be left waiting. This article walks through 3 stocks from...

Why the QUELL-CV Trial Matters for BioAge Labs Stock BioAge Labs (BIOA) has moved its lead drug candidate, BGE-102, into the Phase 2 QUELL-CV trial, a randomized, placebo-controlled study targeting cardiovascular risk in adults with obesity and elevated inflammation. The trial plans to enroll about 160 participants over 12 weeks of once daily dosing, testing three oral dose levels against placebo. The primary focus is change in high-sensitivity C-reactive protein, with additional inflammatory...

With inflation trends shifting, oil prices easing and central banks weighing their next moves, many investors are looking for income streams that feel steadier than short term market headlines. That is where the Dividend Powerhouses screener comes in, focusing on companies with dividend yields above 5% that are covered, growing and relatively stable. In a world of mixed growth signals from the US, Europe and Asia, reliable cash distributions can be a useful anchor for a portfolio. Below,...

National HealthCare (NYSEAM:NHC) has been added to multiple prominent Russell growth indices. This index inclusion reflects Russell’s latest rebalancing and adjusts National HealthCare’s place in key growth benchmarks. The move may affect how institutional investors view and access the stock. National HealthCare enters these Russell growth indices with a recent share price of $206.54 and a reported 3-year return of 263.5%. The stock has also logged a 95.7% return over the past year and is...

Investors were disappointed with Oracle Corporation's ( NYSE:ORCL ) earnings, despite the strong profit numbers. We...

Political tensions around the proposed Save America Act and questions about US institutional strength are back in focus, and that can rattle even seasoned investors. While headlines debate strongman politics and the resilience of courts, media, and the military, some investors are looking again at US blue-chip defensive stocks that may be better suited to handle sharper mood swings in markets. This article walks through 3 stocks from our US Blue-Chip Defensive Stocks screener that appear...

The Supreme Court’s decision to allow more time for counting mail-in ballots has pushed election rules back into the spotlight, and a handful of stocks are closely tied to how those rules are applied on the ground. When voting procedures feel more settled, attention can shift to the companies that help run elections, verify identities, and process ballots. This article looks at three stocks from the Election Technology and Services screener that are directly exposed to the latest mail-in...

The latest cost cutting plan at British American Tobacco, including 9,000 global job cuts and a push toward more digital and AI focused operations, is a reminder that even mature tobacco companies can face sharp shifts in how they run and spend. For investors watching Consumer Defensive stocks, that kind of restructuring can change risk, cash flow priorities, and appetite for nicotine alternatives. This article looks at 3 stocks from our Tobacco & Nicotine Alternatives screener that appear...

Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 19% over the past year with earnings forecasted to grow by 18% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for revenue expansion and innovation while aligning with broader market trends.

Over the last 7 days, the United States market has experienced a 2.5% drop, though it has risen by 19% over the past year with earnings projected to grow by 18% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business in its potential for future success.

Over the last 7 days, the United States market has dropped 2.5%, although it remains up by 19% over the past year and earnings are forecast to grow annually by 18%. Despite being considered a somewhat outdated term, penny stocks still offer intriguing investment opportunities, especially when they involve smaller or newer companies with solid financials. In this article, we examine three promising penny stocks that combine balance sheet strength with potential for significant growth, offering...

Over the last 7 days, the United States market has experienced a 2.5% decline, yet it remains up by 19% over the past year with earnings forecast to grow by 18% annually. In light of these conditions, identifying dividend stocks that offer stable returns and potential for growth can be an effective strategy for investors seeking reliable income streams.

Index additions put Paymentus Holdings in focus Paymentus Holdings (PAY) has just been added to several Russell indices, including the Russell 2000, Russell 2500 and Russell 3000, which may shift how index funds and institutional investors approach the stock. See our latest analysis for Paymentus Holdings. That index news arrives after a sharp short term rebound for Paymentus Holdings, with a 1 day share price return of 10.16% and 7 day share price return of 15.93%. This is set against a year...

The Supreme Court’s decision to shield Federal Reserve Governor Lisa Cook from removal by President Trump, at least for now, keeps the focus on a more predictable, data driven approach to interest rates and liquidity. For large cap financial stocks across banking, insurance, and asset management, clearer expectations around Fed independence can affect funding costs, margins, and investor appetite for risk. This article explores how that backdrop connects to our Large Cap Financial Stocks...

We wouldn't blame Fluence Energy, Inc. ( NASDAQ:FLNC ) shareholders if they were a little worried about the fact that...

Even if it's not a huge purchase, we think it was good to see that James Frew, the President & CFO of Amplify Energy...